跳至主要内容
临床试验/NCT02869230
NCT02869230已完成2 期

Radioguided Occult Lesion Localization (ROLL) is Superior a to the Wire-Guided Lesion Localization (WGLL)? Randomized Controlled Clinical Trial

Instituto Nacional de Cancerologia, Columbia0 个研究点目标入组 129 人开始时间: 2006年3月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
129
主要终点
Localization of nonpalpable breast lesion (percentage)

研究概览

简要总结

Here were present a controlled clinical trial comparing wire-guided lesion localization (WGLL)and radioguided occult lesion localization (ROLL) in patients treated for nonpalpable breast lesions at the Instituto Nacional de Cancerología (National Cancer Institute)in Bogotá,Colombia.

详细描述

The aim of this study was to compare the radioguided occult lesion localization (ROLL) technique with the wire-guided lesion localization (WGLL) technique to assess the optimal localization and excision of nonpalpable breast lesions in patients at a unique reference medical center.

A controlled clinical trial was designed to compare the WGLL and ROLL techniques in women presenting with breast lesions diagnosed by mammography or ultrasound at the Instituto Nacional de Cancerología in Bogotá, Colombia from March 2006 to June 2011.

This study evaluate 129 patients; 64 (49.6%) patients were treated using ROLL and 65 (51.4%) using WGLL.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patients older than 18 years
  • Lesions suggesting malignancy (BIRADS 4 and 5)
  • Solid nodules in postmenopausal women (BIRADS 3 mammograms).

排除标准

  • Pregnant or nursing
  • Patients with suspected multifocal or multicentric disease (suspicious microcalcifications scattered over a wide area on mammography)
  • Patients with retro-areola lesions (less than 2 cm away from the nipple)
  • Lesions that had previously undergone surgery or excisional biopsies in the compromised breast

结局指标

主要结局

Localization of nonpalpable breast lesion (percentage)

时间窗: 30 days

次要结局

  • presence of malignancy(30 days)

研究者

发起方
Instituto Nacional de Cancerologia, Columbia
申办方类型
Other Gov
责任方
Sponsor

相似试验